Based on the results of the 1st to 3rd quarter of 2017, the total value of the hospital segment of the pharmaceutical market reached 92.3 billion rubles, while its volume reached 0.44 billion packages.
Based on the results of the first half of 2017, medicinal products deliveries were made under the High-cost diseases (HCD) program for the amount of almost 25 billion rubles. This is more than a half of the amount budgeted for this item of expenditure for the year. It is assumed that by the end of 2017, the costs of procurement for HCD will exceed 2016’s costs, and will reach the level of previous years
In 2016, the total amount of completed bids for the purchase of medicinal products under Federal Law # 44-FZ reached 304.74 billion rubles, which is 7% higher than a year ago. Approximately 13% were saved, in comparison to the originally announced amount of tenders.